MADDISON BELL: Open Payments
NPI 1952009466 · WOOSTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 30 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $549 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $146 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Lundbeck LLC | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Corium, LLC | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: VRAYLAR, REXULTI, Auvelity, Qelbree, GVOKE HYPOPEN, RECORLEV, Azstarys, ARISTADA.
Industry payments across OH — which companies pay providers there.
